MARKET

THOR

Synthorx
THOR
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-37.7073
-
14.26
1,864,122,080.08
4 Outdoor Stocks To Watch With Record RV Sales Projected In 2021
Motor home sales are seeing strong numbers in 2021, in keeping with the 2020 pre-COVID-19 pandemic, during and after.
Benzinga · 04/13 18:15
Monday Morning Market Highlights
GuruFocus.com · 06/08/2020 18:11
Sanofi finalizes Synthorx buy
seekingalpha · 01/23/2020 19:46
IBKC, THOR, TIF, and AMTD SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
GlobeNewswire · 01/09/2020 18:15
WAAS, TIVO, THOR, and CRCM SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
GlobeNewswire · 01/07/2020 05:00
Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm
PR Newswire · 01/06/2020 16:07
CBB, TGE, INST, and THOR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
GlobeNewswire · 01/02/2020 20:00
THOR, ARQL, TIF, and AMTD SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
GlobeNewswire · 12/28/2019 19:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of THOR. Analyze the recent business situations of Synthorx through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average THOR stock price target is 68.00 with a high estimate of 68.00 and a low estimate of 68.00.
EPS
Institutional Holdings
Institutions: 42
Institutional Holdings: 21.18M
% Owned: 77.26%
Shares Outstanding: 27.42M
TypeInstitutionsShares
Increased
17
494.68K
New
7
120.15K
Decreased
6
670.73K
Sold Out
1
465
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.57%
Pharmaceuticals & Medical Research
-0.98%
Key Executives
Chairman/Independent Director
Pratik Shah
President/Chief Executive Officer/Director/Primary Contact
Laura Shawver
Chief Financial Officer
Tighe Reardon
Chief Scientific Officer
Marcos Milla
Other
Joseph Leveque
Director
Jay Lichter
Independent Director
Vickie Capps
Independent Director
Peter Kolchinsky
Independent Director
Andrew Powell
Independent Director
Peter Thompson
No Data

Webull offers kinds of Synthorx stock information, including NASDAQ:THOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, THOR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading THOR stock methods without spending real money on the virtual paper trading platform.